TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  The Motley Fool

Why Amgen Stock Was Crushing It on Wednesday

The Motley Fool Logo The Motley Fool By Eric Volkman
Why Amgen Stock Was Crushing It on Wednesday

Amgen reported strong Q3 2025 financial results, with 12% year-over-year revenue growth to $9.6 billion and raised full-year guidance, leading to an 8.38% stock price increase.

Insights
SYFpB   neutral

Flat revenue performance with a slight stock decline of -3.5%


AMGN   positive

Exceeded analyst expectations with 12% revenue growth, raised full-year guidance, strong performance of key drugs, and positive CEO outlook for future innovation and growth